ATAI Life Stock Valuation

ATAI
 Stock
  

USD 3.34  0.21  5.92%   

Do you want to know what the current value of ATAI Life Sciences is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as ATAI Life, is its stock price multiplied by the total number of shares outstanding, calculating ATAI Life's enterprise value requires a different approach. It uses ATAI Life's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
ATAI Life Sciences owns a latest Real Value of $10.37 per share. The recent price of the firm is $3.34. At this time, the firm appears to be undervalued. Our model approximates the value of ATAI Life Sciences from analyzing the firm fundamentals such as return on asset of (0.22) %, and Shares Owned by Insiders of 9.28 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor locking in undervalued equities and disposing overvalued equities since, in the future, asset prices and their ongoing real values will grow together.
  
ATAI Life Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as ATAI Life's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

ATAI Life Most Recent Valuation Data

Fiscal Year End
December
property Plant And Equipment Net
149 K
Enterprise Value
299.8 M
net Debt
-362.3 M
accounts Payable
M
non Currrent Assets Other
11.2 M
Undervalued
Today 3.34
Please note that ATAI Life's price fluctuation is slightly risky at this time. Calculation of the real value of ATAI Life Sciences is based on 3 months time horizon. Increasing ATAI Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for ATAI Life Sciences is useful when determining the fair value of the ATAI Life stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of ATAI Life. Since ATAI Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ATAI Life Stock. However, ATAI Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
10.37
Real Value
15.10
Upside
Estimating the potential upside or downside of ATAI Life Sciences helps investors to forecast how ATAI Life stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ATAI Life more accurately as focusing exclusively on ATAI Life's fundamentals will not take into account other important factors:
Earnings
Estimates (4)
LowProjected EPSHigh
-0.95-0.8-0.67
Details
Hype
Prediction
LowEstimated ValueHigh
0.173.348.07
Details
11 Analysts
Consensus
LowTarget PriceHigh
17.0031.7850.00
Details

ATAI Life Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining ATAI Life's current stock value. Our valuation model uses many indicators to compare ATAI Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ATAI Life competition to find correlations between indicators driving ATAI Life's intrinsic value. More Info.
ATAI Life Sciences is number one stock in net asset category among related companies. It is number one stock in price to book category among related companies . The ratio of Net Asset to Price to Book for ATAI Life Sciences is about  228,669,390 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ATAI Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ATAI Life's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ATAI Life's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ATAI Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ATAI Life and how it compares across the competition.

About ATAI Life Valuation

The stock valuation mechanism determines the current worth of ATAI Life Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of ATAI Life Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of ATAI Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing ATAI Life's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ATAI Life's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ATAI Life. We calculate exposure to ATAI Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ATAI Life's related companies.
Fiscal Year End
December
Industry
Biotechnology
Full Time Employees
87.0
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.

ATAI Life Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as ATAI Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quarterly Earnings Growth Y O Y-0.968
Please continue to Trending Equities. Note that the ATAI Life Sciences information on this page should be used as a complementary analysis to other ATAI Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for ATAI Life Stock analysis

When running ATAI Life Sciences price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is ATAI Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.97) 
Market Capitalization
588.9 M
Quarterly Revenue Growth YOY
(0.91) 
Return On Assets
(0.22) 
Return On Equity
(0.54) 
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI Life that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine ATAI Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.